248 related articles for article (PubMed ID: 30943578)
1. Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives.
Berquist SW; Yim K; Ryan ST; Patel SH; Eldefrawy A; Cotta BH; Bradshaw AW; Meagher MF; Bindayi A; McKay RR; Autorino R; Staehler M; Derweesh IH
Int J Urol; 2019 May; 26(5):532-542. PubMed ID: 30943578
[TBL] [Abstract][Full Text] [Related]
2. Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma.
Ghali F; Patel SH; Derweesh IH
J Oncol; 2019; 2019():7309205. PubMed ID: 31057615
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant therapy for localized and locally advanced renal cell carcinoma.
Bindayi A; Hamilton ZA; McDonald ML; Yim K; Millard F; McKay RR; Campbell SC; Rini BI; Derweesh IH
Urol Oncol; 2018 Jan; 36(1):31-37. PubMed ID: 28802883
[TBL] [Abstract][Full Text] [Related]
4. The current role for adjuvant and neoadjuvant therapy in renal cell cancer.
Gleeson JP; Motzer RJ; Lee CH
Curr Opin Urol; 2019 Nov; 29(6):636-642. PubMed ID: 31348025
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?
Martinez Chanza N; Tripathi A; Harshman LC
Curr Treat Options Oncol; 2019 May; 20(5):44. PubMed ID: 31054006
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies for advanced renal cell carcinoma: A new paradigm for surgical treatment.
Tomita Y
Int J Urol; 2016 Jan; 23(1):13-21. PubMed ID: 26347163
[TBL] [Abstract][Full Text] [Related]
7. Role of targeted therapy in combination with surgery in renal cell carcinoma.
Bex A; Powles T; Karam JA
Int J Urol; 2016 Jan; 23(1):5-12. PubMed ID: 26238981
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy in renal cell carcinoma: is resection still solely enough?
Gharib KE
Future Oncol; 2021 Feb; 17(6):633-636. PubMed ID: 33305597
[No Abstract] [Full Text] [Related]
9. Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma.
Westerman ME; Shapiro DD; Wood CG; Karam JA
Urol Clin North Am; 2020 Aug; 47(3):329-343. PubMed ID: 32600535
[TBL] [Abstract][Full Text] [Related]
10. Current evidence and the evolving role of sunitinib in the management of renal cell carcinoma.
Noronha V; Joshi A; Bakshi G; Tongaonkar H; Prabhash K
Indian J Cancer; 2016; 53(1):102-8. PubMed ID: 27146754
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
Lenis AT; Donin NM; Johnson DC; Faiena I; Salmasi A; Drakaki A; Belldegrun A; Pantuck A; Chamie K
J Urol; 2018 Jan; 199(1):43-52. PubMed ID: 28479237
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of locally advanced renal tumors].
Sánchez Zalabardo D; Millán Serrano JA; De Pablo Cárdenas A; Cuesta Alcalá JA
Actas Urol Esp; 2010 Feb; 34(2):134-41. PubMed ID: 20403277
[TBL] [Abstract][Full Text] [Related]
13. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
14. The potential role for neoadjuvant therapy in renal cell carcinoma.
Ho D; Kim HL
Clin Adv Hematol Oncol; 2013 Dec; 11(12):777-82. PubMed ID: 24893281
[TBL] [Abstract][Full Text] [Related]
15. Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma.
Kapoor A; Kim J; Goucher G; Hoogenes J
Urol Clin North Am; 2020 Aug; 47(3):271-280. PubMed ID: 32600530
[TBL] [Abstract][Full Text] [Related]
16. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M
Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207
[TBL] [Abstract][Full Text] [Related]
17. Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects.
Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Nishikawa T; Nakano M; Tanabe K
Jpn J Clin Oncol; 2010 Dec; 40(12):1173-9. PubMed ID: 20696817
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma.
Flippot R; Escudier B; Albiges L
Drugs; 2018 Sep; 78(14):1443-1457. PubMed ID: 30187355
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant and adjuvant treatment of renal cell carcinoma.
Thillai K; Allan S; Powles T; Rudman S; Chowdhury S
Expert Rev Anticancer Ther; 2012 Jun; 12(6):765-76. PubMed ID: 22716493
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.
Silberstein JL; Millard F; Mehrazin R; Kopp R; Bazzi W; DiBlasio CJ; Patterson AL; Downs TM; Yunus F; Kane CJ; Derweesh IH
BJU Int; 2010 Nov; 106(9):1270-6. PubMed ID: 20394613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]